Butterfly Network Announces 5-Year Co-Development Agreement with Forest Neurotech for Next-generation Brain Computer Interfaces Using Ultrasound-on-Chip Technology - Seite 2

Since launching Butterfly Garden, Butterfly has seen a strong response to the program and the company expects additional collaboration announcements to follow.

Butterfly continues to accept applications for third-party development on a rolling basis. To learn more or apply, visit https://www.butterflynetwork.com/butterfly-garden.

About Butterfly Network

Founded by Dr. Jonathan Rothberg in 2011 and listed on the New York Stock Exchange through a business combination with Longview Acquisition Corp., Butterfly created the world's first handheld, single probe whole-body ultrasound system using semiconductor technology, the Butterfly iQ+. Butterfly's mission is to democratize medical imaging and contribute to the aspiration of global health equity, making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Through its proprietary Ultrasound-on-Chip technology, Butterfly is paving the way for earlier detection and remote management of health conditions around the world. The Butterfly iQ+ can be purchased today by trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit: www.butterflynetwork.com/choose-your-country.

About Forest Neurotech

Forest Neurotech is a Focused Research Organization (FRO) developing an ultrasound based BCI and software platform with the aim of catalyzing breakthroughs in both the understanding and personalized treatment of the human brain. Ultrasound is capable of measuring and stimulating brain-wide activity in a minimally invasive manner. This opens new avenues for research into personalized therapies across a range of psychiatric and cognitive disorders. As a FRO, Forest Neurotech has the freedom to focus solely on advancing science and engineering for the public good. Pioneered by Convergent Research, a member of the Schmidt Futures Network, FROs are designed to overcome key technological bottlenecks for the advancement of science and medicine. Forest Neurotech is based in California, co-founded by former Caltech scientists and a former Google executive. For more information, visit www.forestneurotech.org.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231024884034/en/

The Butterfly Network Registered (A) Stock at the time of publication of the news with a fall of -1,95 % to 0,824USD on NYSE stock exchange (24. Oktober 2023, 02:04 Uhr).